929 results on '"Dawson, Valina L."'
Search Results
2. α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease
3. Author Correction: Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
4. Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity
5. Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
6. Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke
7. Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide
8. The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives
9. Interspecies chimerism with human embryonic stem cells generates functional human dopamine neurons at low efficiency
10. Apoptotic cell death in disease—Current understanding of the NCCD 2023
11. Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
12. Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly
13. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson’s disease
14. CYFIP1 Dosages Exhibit Divergent Behavioral Impact via Diametric Regulation of NMDA Receptor Complex Translation in Mouse Models of Psychiatric Disorders
15. AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
16. Poly ADP-ribose signaling is dysregulated in Huntington disease.
17. Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis
18. Nanozyme scavenging ROS for prevention of pathologic α-synuclein transmission in Parkinson’s disease
19. Gastrointestinal tract cleavage of α-synuclein by asparaginyl endopeptidase leads to Parkinson's disease.
20. AIF3 splicing switch triggers neurodegeneration
21. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
22. Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation
23. Blocking the Self-Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition.
24. Poly(ADP‐ribose) mediates bioenergetic defects and redox imbalance in neurons following oxygen and glucose deprivation.
25. Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
26. Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
27. GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers
28. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
29. Leucine-Rich Repeat Kinase 2 (LRRK2) Interacts with Parkin, and Mutant LRRK2 Induces Neuronal Degeneration
30. Parkinson's Disease-Associated Mutations in Leucine-Rich Repeat Kinase 2 Augment Kinase Activity
31. Failure to Degrade Poly(ADP-Ribose) Causes Increased Sensitivity to Cytotoxicity and Early Embryonic Lethality
32. Loss of Locus Coeruleus Neurons and Reduced Startle in Parkin Null Mice
33. S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function
34. Identification and Analysis of Plasticity-Induced Late-Response Genes
35. Identification of Calcium- and Nitric Oxide-Regulated Genes by Differential Analysis of Library Expression (DAzLE)
36. Molecular Pathways of Neurodegeneration in Parkinson's Disease
37. Apoptosis-Inducing Factor Is Involved in the Regulation of Caspase-Independent Neuronal Cell Death
38. Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
39. Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid
40. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
41. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity
42. FKBP12, The 12-kDa FK506-Binding Protein, is a Physiologic Regulator of the Cell Cycle
43. Brain Serotonin Dysfunction Accounts for Aggression in Male Mice Lacking Neuronal Nitric Oxide Synthase
44. Protein Translation in the Pathogenesis of Parkinson's Disease.
45. Parkin Functions as an E2-Dependent Ubiquitin-Protein Ligase and Promotes the Degradation of the Synaptic Vesicle-Associated Protein, CDCrel-1
46. Dynamic Regulation of Neuronal NO Synthase Transcription by Calcium Influx through a CREB Family Transcription Factor-Dependent Mechanism
47. Requirement for Nitric Oxide Activation of p21 ras /extracellular Regulated Kinase in Neuronal Ischemic Preconditioning
48. Poly(ADP-Ribose) Polymerase Activation Mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Induced Parkinsonism
49. Nitric Oxide Mediates N-methyl-D-Aspartate Receptor-Induced Activation of p21 ras
50. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.